Omeros director granted 15,000 stock options

Omeros Corporation director Rajiv Shah received a grant of stock options covering 15,000 shares of common stock.

Rhea-AI Filing Summary

Omeros Corporation director Rajiv Shah received a grant of stock options covering 15,000 shares of common stock. The options have an exercise price of $10.28 per share and expire on June 17, 2036. The award was made under Omeros’ non-employee director compensation policy in connection with the June 18, 2026 annual shareholder meeting.

The option will fully vest and become exercisable on the day before the company’s 2027 annual shareholder meeting, as long as Shah continues serving as a director through that date. Following this grant, he holds 15,000 stock options directly.

Insider Trade Summary

Grant/Award: 15,000 shares

Grant/Award 1 txn

Insider Shah Rajiv

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	15,000	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 15,000 contracts (Direct)

Footnotes (2)

1. F1. Pursuant to Omeros Corporation's non-employee director compensation policy, on the date of each annual meeting of shareholders, each non-employee director who has served as a director for at least six months and who will continue to serve as a director after the annual meeting is automatically granted an option to purchase 15,000 shares of common stock. This Form 4 reports the annual stock option award granted to the reporting person in conjunction with the annual meeting of shareholders held on June 18, 2026.
2. F2. This option will fully vest and become exercisable on the day before the date of the 2027 annual meeting of the shareholders of Omeros Corporation, provided that the reporting person continues to serve as a director of the company through such date.

Key Figures

Option grant size: 15,000 shares Exercise price: $10.28 per share Expiration date: June 17, 2036 +2 more

5 metrics

Option grant size 15,000 shares Stock option (right to buy) granted to director Rajiv Shah

Exercise price $10.28 per share Exercise price of the 15,000-share stock option grant

Expiration date June 17, 2036 Option expiration date for Rajiv Shah’s director grant

Post-grant derivative holdings 15,000 options Total stock options held directly following this transaction

Grant date June 18, 2026 Annual stock option award date tied to shareholder meeting

Key Terms

non-employee director compensation policy, stock option, exercise price, vest

4 terms

non-employee director compensation policy financial

"Pursuant to Omeros Corporation's non-employee director compensation policy, on the date of each annual meeting..."

stock option financial

"each non-employee director ... is automatically granted an option to purchase 15,000 shares of common stock."

A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

exercise price financial

"Stock Option (Right to Buy) ... conversion_or_exercise_price: 10.2800"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vest financial

"This option will fully vest and become exercisable on the day before the date of the 2027 annual meeting..."

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Omeros (OMER) director Rajiv Shah report in this Form 4?

Director Rajiv Shah reported receiving a grant of stock options for 15,000 shares of Omeros common stock. The grant is part of the company’s non-employee director compensation policy tied to the June 18, 2026 annual shareholder meeting.

What are the key terms of Rajiv Shah’s 15,000 Omeros (OMER) stock options?

Rajiv Shah’s options cover 15,000 Omeros common shares at a $10.28 exercise price per share. The options expire on June 17, 2036 and were granted as a standard non-employee director annual award, not an open-market purchase.

When do Rajiv Shah’s Omeros (OMER) director stock options vest?

The option grant will fully vest and become exercisable on the day before Omeros’ 2027 annual shareholder meeting. Vesting requires that Rajiv Shah continue serving as a director of the company through that date, according to the disclosed compensation policy.

How many Omeros (OMER) stock options does Rajiv Shah hold after this transaction?

After this grant, Rajiv Shah directly holds 15,000 Omeros stock options. This Form 4 reflects only the annual non-employee director option award and does not show any open-market buying or selling of Omeros common stock by Shah.

Is Rajiv Shah’s Omeros (OMER) Form 4 transaction a market buy or sell?

No, the Form 4 shows a grant of stock options as director compensation, not a market trade. The transaction is coded as an acquisition (grant/award), with no shares bought or sold in the open market on the reported date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/22/2026 - 07:35 AM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Shah Rajiv

(Last) (First) (Middle)

201 ELLIOTT AVENUE WEST

(Street)

SEATTLE WASHINGTON 98119

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
OMEROS CORP [ OMER ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)(1)	$10.28	06/18/2026		A		15,000		(2)	06/17/2036	Common Stock	15,000	$0	15,000	D

Explanation of Responses:

1. Pursuant to Omeros Corporation's non-employee director compensation policy, on the date of each annual meeting of shareholders, each non-employee director who has served as a director for at least six months and who will continue to serve as a director after the annual meeting is automatically granted an option to purchase 15,000 shares of common stock. This Form 4 reports the annual stock option award granted to the reporting person in conjunction with the annual meeting of shareholders held on June 18, 2026.

2. This option will fully vest and become exercisable on the day before the date of the 2027 annual meeting of the shareholders of Omeros Corporation, provided that the reporting person continues to serve as a director of the company through such date.

	/s/ Peter B. Cancelmo, Attorney-in-Fact	06/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)